# ‚úÖ Phase 69 & 70: Sustainability & Science

## üöÄ Overview

We have added two sophisticated layers to ensure the center's financial sustainability and scientific contribution:

1.  **Smart Philanthropy:** Manages the donor lifecycle and funding matching.
2.  **Smart Research:** Manages clinical usage of data for scientific advancement.

---

## üéÅ Phase 69: Smart Philanthropy & Grants (Sustainability)

**Goal:** Optimize funding by proving impact to donors.

### Key Features

- **AI Sponsorship Matcher:** `POST /api/philanthropy-smart/match-sponsor`
  - Matches donors (e.g., "Interested in Cerebral Palsy") with specific, anonymized needy cases.
  - Ensures funds go where they are most needed and aligned with donor intent.
- **Automated Impact Reports:** `GET /api/philanthropy-smart/impact-report`
  - Generates reports showing exactly how a donation was used (e.g., "Your $500 bought 5 therapy sessions").
  - Increases donor retention.

### Architecture

- **Service:** `backend/services/smartPhilanthropy.service.js`
- **Routes:** `backend/routes/philanthropy_smart.routes.js`

---

## üî¨ Phase 70: Smart Research & Clinical Trials (Science)

**Goal:** Turn clinical data into scientific knowledge securely.

### Key Features

- **Cohort Identification:** `POST /api/research-smart/cohort-id`
  - Quickly finds patients matching study criteria (e.g., "Autism, Age 5-10, No Medication").
  - Calculates prevalence rates instantly.
- **Anonymized Data Lake Export:** `POST /api/research-smart/export-data`
  - Strips all PII (Names, IDs) and exports clean CSV/JSON for researchers.
  - Enforces Ethical Board (IRB) approval checks before export.
- **Protocol Efficacy Analysis:**
  - Compares outcomes of different treatment methods (A/B Testing for therapies).

### Architecture

- **Service:** `backend/services/smartResearch.service.js`
- **Routes:** `backend/routes/research_smart.routes.js`

---

## üîÆ What this means

The system is now a **Teaching & Research Hospital Grade** ERP, capable not just of operations, but of funding itself and contributing to global medical science.
